Clinical and economic evaluation of oral ciprofloxacin after an abbreviated course of intravenous antibiotics

The American Journal of Medicine

Volumn 91, Issue 5, 1991, Pages 462-470

  Paladino, Joseph A ^a   Sperry, Howard E ^a   Backes, Julie M ^a   Gelber, Jeffrey A ^a   Serrianne, Deborah J ^a   Cumbo, Thomas J ^a   Schentag, Jerome J ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; NAFCILLIN; VANCOMYCIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; COLITIS; CONTROLLED STUDY; COST; DIARRHEA; DRUG EFFICACY; ESCHERICHIA COLI; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PRURITUS; PSEUDOMONAS AERUGINOSA; RASH; STAPHYLOCOCCUS AUREUS;

ADMINISTRATION, ORAL; ADULT; ANTIBIOTICS; BACTERIAL INFECTIONS; CIPROFLOXACIN; COMPARATIVE STUDY; COSTS AND COST ANALYSIS; HUMAN; INFUSIONS, INTRAVENOUS; PATIENT COMPLIANCE; STATISTICS; SUPPORT, NON-U.S. GOV'T; TREATMENT OUTCOME;

EID: 0026316334     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9343(91)90181-V     Document Type: Article

References (33)

1. Economic impact of streamlining antibiotic administration
2. The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro
3. In vitro activity of ciprofloxacin (Bay o 9867)
4. Ciprofloxacin: in vitro activity, mechanism of action, and resistance
5. Pharmacokinetics of ciprofloxacin: intravenous and increasing oral doses
6. Tissue penetration of ciprofloxacin after single and multiple doses
7. Tissue penetration and metabolism of ciprofloxacin
8. Brief report respiratory tract penetration of ciprofloxacin
9. Cost-effective antibiotic prescribing
10. Cost containment of reconstituted parenteral antibiotics: personnel and supply costs associated with preparation, dispensing, and administration
11. Interactions affecting drug absorption
12. Interactions of ciprofloxacin with clindamycin, metronidazole, cefoxitin, cefotaxime and mezlocillin against gram-positive and gram-negative anaerobic bacteria
13. Liquid-chromatographic determination of ciprofloxacin in serum and urine
14. Cost analysis of a home intravenous antibiotic program
15. Oral chloramphenicol in the treatment of Hemophilus influenzae meningitis
16. Options for outpatient management of serious infections
17. Evaluation of intravenous ciprofloxacin in patients with nosocomial lower respiratory tract infections
18. Oral ciprofloxacin in the treatment of serious soft tissue and bone infections
19. Multiple dose pharmacokinetics and safety of ciprofloxacin in normal volunteers
20. How often is medication taken as prescribed?
21. Compliance with topical timolol treatment
22. Time to stop counting the tablets?
23. The natural history of medication compliance in a drug trial: limitations of pill counts
24. Intravenous antibiotic therapy in an outpatient setting
25. Cost-effectiveness of outpatient parenteral antibiotics: a review of the literature
26. latrogenic illness on a general medical service at a university hospital
27. Is there cost reduction potential for extended half-life cephalosporins?
28. Using clinical interventions to cost-justify additional pharmacy staff
29. Documentation of clinical interactions: quality of care issues and economic considerations in critical care pharmacy
30. Converting intravenous cimetidine and ranitidine therapy to oral therapy [letter]
31. Hospital drug expenditures in 1985 [letter]
32. Hospital drug expenditures in 1985 [letter]